Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Study of Add-on Therapy With CK0804 in Patients With MF With a Suboptimal Response to Ruxolitinib"
By
Insights from 2023 ASH Annual Meeting
FEATURING
Lucia Masarova
By
Insights from 2023 ASH Annual Meeting
FEATURING
Lucia Masarova
Login to view comments.
Click here to Login